You are on page 1of 1

Contract Bio-Manufacturing

Description: Use and Sale- Meets Point of Care Use Requirements, Use Pathways; e.g.,
Licensing, USA Only or International or Both, More than Minimal Manipulation, Living Cells or
Derivative, Pre-clinical Testing, IND(s) Clinical Studies, Customers & Markets, Disease Targets,
COGS vs. Pricing, Secondary Vendors, Claims & Monitoring. Ship, Store, Shelf Life- Inventory
&Tracking, Validated Shippers, GMP CryoMedia, High Recovery, Stability Testing.
Procurement- Autologous or Allogeneic Resection vs Other (e.g., Liposuction), Transport Reagents,
Methods, Kits, Contracts/Agreements: e.g., ICD; COC; OPO. Processing- Rinsing; Dissociation
Counting & Viability, Optional: Culture Cells QC Release: Potency =#+ Bioassays; Identity =
biomarker[s]; Safety = endotoxin, sterility, (option) mycoplasma, Further Processing; More Testing.
Components Meet GMP and CMC Needs for INDs- Processing & Manufacturing Materials: Only
High Quality Materials- Active ingredient (e.g., cells), raw Materials and excipients in final product,
Collection, reagents, solutions, cryostorage media, enzymes: made GMP, Bags, centrifuge
containers, connectors: qualified vendors.

Reference URL: http://medical.wesrch.com/paper-details/pdf-ME1XXFD1PPSSM-contract-bio


-manufacturing

You might also like